InteliSwab® makes it easier for individuals with or without symptoms to test themselves anytime, anywhere, and take all the necessary precautions if they test positive.
With Emergency Use Authorization for over-the-counter use, prescription home use and point-of-care use, InteliSwab® can meet the needs of any employer, university, physician office, public health testing site or venue large or small.
Interested in purchasing bulk test quantities for your organization?
Please contact us.
Stay up to date with our latest news
Swab.
Swirl.
See.
There are no confusing steps, no batteries and no mailing to labs.
You just swab your nostrils with the gentle swab, swirl it in the tube, and see results in minutes.
It’s just that simple. That's the power of InteliSwab®.
This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA.
This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
C is the control line. T is the test line that shows the result within minutes.
Any line next to the “T” means you may have COVID-19, even if the line is very faint.
NEGATIVE
POSITIVE
POSITIVE
POSITIVE
INVALID
INVALID
January 31, 2022
OraSure Technologies Inc. said its InteliSwab® Covid-19 rapid tests have been authorized by the U.S. Food and Drug Administration for use in children ages 2 to 14.
January 14, 2022
Consumers who are fortunate enough to get their hands on over-the-counter, rapid COVID-19 tests will soon be reimbursed by their insurers for the cost of such devices under new rules outlined by the White House this week.
November 20, 2021
As a risk-reduction measure, you might want to ask your guests to take a COVID test before a large holiday get together.
September 20, 2021
OraSure Technologies has been awarded a $205 million contract from a federal defense agency for the use of its rapid COVID-19 test.
September 20, 2021
OraSure Technologies Inc. said the Defense Logistics Agency has awarded it an estimated $205 million procurement contract for the company's InteliSwab® Covid-19 rapid test for over-the-counter use.
September 20, 2021
The US Department of Defense announced on Friday that in coordination with the US Department of Health and Human Services it has awarded four procurement contracts totaling $647 million to four companies to purchase over-the-counter COVID-19 test kits.
June 7, 2021
These tests detect active COVID-19 infection; the agency has given the emergency nod for Over-the-Counter use.
InteliSwab® is designed and developed in Bethlehem, Pennsylvania by OraSure, a leading innovator in diagnostic testing for infectious disease - and the creator of the first in-home HIV test. Now, OraSure has leveraged its expertise to develop COVID-19 testing solutions.
Contact Us
